S. Spellman

发表

Population frequency of Fanconi pathway gene variants and their association with survival after hematopoietic cell transplant for severe aplastic anemia.

S. Savage, K. Jones, B. Zhu, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Tools for the Precision Medicine Era: How to Develop Highly Personalized Treatment Recommendations From Cohort and Registry Data Using Q-Learning

Brent Logan, Daniel Couriel, E. Moodie, 2017, American journal of epidemiology.

Fast and accurate HLA typing from short-read next-generation sequence data with xHLA

E. Kirkness, J. Venter, J. Venter, 2017, Proceedings of the National Academy of Sciences.

Guidelines for the development and validation of new potency assays for the evaluation of umbilical cord blood.

J. Kurtzberg, J. Reems, S. Spellman, 2011, Cytotherapy.

Iterative feature selection method to discover predictive variables and interactions for high-dimensional transplant genomic data

S. Spellman, C. Vierra-Green, Hu Huang, 2019, bioRxiv.

High HLA-DP Expression and Graft-versus-Host Disease.

Effie W Petersdorf, Mari Malkki, Mary Carrington, 2015, The New England journal of medicine.

Association of donor IFNL4 genotype and non-relapse mortality after unrelated donor myeloablative haematopoietic stem-cell transplantation for acute leukaemia: a retrospective cohort study.

Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, L. Prokunina-Olsson, 2020, The Lancet. Haematology.

Hematopoietic cell transplantation with cord blood for cure of HIV infections.

J. Kurtzberg, E. Shpall, J. Rossi, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets.

L. Weiner, Jeffrey S. Miller, J. Ross, 2014, Blood.

MYELOID NEOPLASIA CD 16 xCD 33 bispeci fi c killer cell engager ( BiKE ) activates NK cells against primary MDS and MDSC CD 33 1 targets

L. Weiner, Jeffrey S. Miller, J. Ross, 2014 .

Revealing complete complex KIR haplotypes phased by long-read sequencing technology

S. Ranade, R. Kuang, K. Eng, 2017, Genes and Immunity.

Evaluation of a Machine Learning-Based Prognostic Model for Unrelated Hematopoietic Cell Transplantation Donor Selection.

K. Hsu, Stephanie J. Lee, S. Spellman, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Molecular Correlates of Socioeconomic Status and Clinical Outcomes Following Hematopoietic Cell Transplantation for Leukemia

Stephanie J. Lee, S. Spellman, Tao Wang, 2019, JNCI cancer spectrum.

Determining the Quantitative Principles of T Cell Response to Antigenic Disparity in Stem Cell Transplantation

M. Neale, G. Buck, M. Manjili, 2018, Front. Immunol..

Donor KIR Gene Content and KIR-Ligand Matching and Outcomes of Pediatric Patients with JMML Following Unrelated Donor Transplant.

Stephanie J. Lee, S. Marsh, S. Spellman, 2021, Transplantation and cellular therapy.

Investigation of donor KIR content and matching in children undergoing hematopoietic cell transplantation for acute leukemia.

Jeffrey S. Miller, Stephanie J. Lee, S. Spellman, 2020, Blood advances.

KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation.

P. Parham, K. van Besien, S. Farag, 2020, Blood advances.

Donor Killer Cell Immunoglobulin-Like Receptor Genotype Does Not Improve Graft-versus-Leukemia Responses in Chronic Lymphocytic Leukemia after Unrelated Donor Transplant: A Center for International Blood and Marrow Transplant Research Analysis.

P. Parham, Jeffrey S. Miller, Stephanie J. Lee, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

KIR Donor Selection: Feasibility in Identifying better Donors.

P. Parham, S. Marsh, S. Spellman, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Killer Cell Immunoglobulin-Like Receptor-Ligand Matching and Outcomes after Unrelated Cord Blood Transplantation in Acute Myeloid Leukemia.

F. Locatelli, S. Spellman, Tao Wang, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.

J. Chewning, K. Hsu, B. Dupont, 2012, The New England journal of medicine.

HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation.

J. Klein, Stephanie J. Lee, O. Ringdén, 2011, Biology of Blood and Marrow Transplantation.

Decreased infections in recipients of unrelated donor hematopoietic cell transplantation from donors with an activating KIR genotype.

J. Klein, Jeffrey S. Miller, S. Spellman, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation.

K. Hsu, M. Malkki, S. Spellman, 2010, Blood.

KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation.

Jeffrey S. Miller, S. Spellman, D. Weisdorf, 2005, Blood.

Reperfusion injury after focal cerebral ischemia: the role of inflammation and the therapeutic horizon.

E. Nussbaum, W. Low, S. Spellman, 1998, Neurosurgery.

Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant Research

M. Horowitz, J. Pidala, Stephanie J. Lee, 2016, Haematologica.

Chronic Graft-Versus-Host Disease, Non-Relapse Mortality and Disease Relapse in Older versus Younger Adults Undergoing Matched Allogeneic Peripheral Blood Hematopoietic Cell Transplantation: A CIBMTR Analysis.

J. Pidala, L. Lekakis, V. Bhatt, 2021, Transplantation and cellular therapy.

GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia.

M. Aljurf, J. Szer, R. Gale, 2019, Blood advances.

Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants.

M. Norkin, H. Nakasone, M. Aljurf, 2018, Blood advances.

Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis.

M. Aljurf, M. Horowitz, R. Gale, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease.

J. Klein, M. Horowitz, J. Wingard, 2011, Blood.

Multiple functional variants in the IL1RL1 region are pretransplant markers for risk of GVHD and infection deaths.

Lara E Sucheston-Campbell, Abbas A. Rizvi, C. Haiman, 2019, Blood advances.

A cure‐rate model for Q‐learning: Estimating an adaptive immunosuppressant treatment strategy for allogeneic hematopoietic cell transplant patients

E. Moodie, D. Stephens, S. Spellman, 2019, Biometrical journal. Biometrische Zeitschrift.

M. Maiers, S. Spellman, M. Albrecht, 2016, Bone Marrow Transplantation.

Patient HLA Germline Variation and Transplant Survivorship.

R. Strong, M. Horowitz, M. Malkki, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic Mutations in Myelodysplastic Syndrome after Stem‐Cell Transplantation

D. Neuberg, B. Ebert, K. Hsu, 2017, The New England journal of medicine.

Prognostic impact of serum CXC chemokine ligands 4 and 7 on myelodysplastic syndromes post allogeneic hematopoietic cell transplant

K. Hsu, Stephanie J. Lee, S. Spellman, 2020, Leukemia & lymphoma.

161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS.

Jeffrey S. Miller, S. Spellman, D. Weisdorf, 2018, Blood advances.

Genome-Wide Association Analyses Identify Variants in IRF4 Associated With Acute Myeloid Leukemia and Myelodysplastic Syndrome Susceptibility

Lara E Sucheston-Campbell, Abbas A. Rizvi, Lara E. Sucheston-Campbell, 2019, bioRxiv.

Adaptive NK Cells with Low TIGIT Expression Are Inherently Resistant to Myeloid-Derived Suppressor Cells.

Bin Zhang, Jeffrey S. Miller, S. Spellman, 2016, Cancer research.

Updated Trends in Hematopoietic Cell Transplantation in the United States with an Additional Focus on Adolescent and Young Adult Transplantation Activity and Outcomes.

M. Pasquini, Stephanie J. Lee, B. Shaw, 2022, Transplantation and cellular therapy.

Effect of Recipient Age and Stem Cell Source on the Association between Donor Telomere Length and Survival after Allogeneic Unrelated Hematopoietic Cell Transplantation for Severe Aplastic Anemia.

S. Savage, H. Katki, K. Jones, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most.

D. Porter, M. Horowitz, K. Hsu, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Chain-terminating natural mutations affect the function of activating KIR receptors 3DS1 and 2DS3

E. Reed, S. Spellman, R. Rajalingam, 2007, Immunogenetics.

Antagonism of leukocyte adherence by synthetic fibronectin peptide V in a rat model of transient focal cerebral ischemia.

P. Camarata, W. Low, S. Spellman, 1997, Neurosurgery.

Reduction of brain injury using heparin to inhibit leukocyte accumulation in a rat model of transient focal cerebral ischemia. I. Protective mechanism.

T. Oegema, P. Camarata, W. Low, 1996, Journal of neurosurgery.

Synthetic fibronectin peptides and ischemic brain injury after transient middle cerebral artery occlusion in rats.

P. Camarata, W. Low, S. Spellman, 1996, Journal of neurosurgery.

Awareness and acceptance of public cord blood banking among practicing obstetricians in the United States

S. Spellman, M. Boo, Tim Walker, 2012, Transfusion.

Donor and recipient chemokine receptor CCR5 genotype is associated with survival after bone marrow transplantation.

R. Abdi, S. Ricklefs, S. Porcella, 2010, Blood.

Telomere length and epigenetic clocks as markers of cellular aging: a comparative study

S. Horvath, S. Savage, B. Hicks, 2022, GeroScience.

Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide.

R. Vij, D. Lad, M. Perales, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Synthetic fibronectin peptide exerts neuroprotective effects on transient focal brain ischemia in rats

W. Low, S. Spellman, W. Duan, 2005, Brain Research.

Role of HLA-B Exon 1 in Graft-versus-Host Disease After Unrelated Donor Transplantation: A Retrospective Cohort Study

K. Hsu, M. Maiers, M. Malkki, 2020 .

HLA-B Leader and Survivorship after HLA-Mismatched Unrelated Donor Transplantation.

M. Carrington, M. Horowitz, K. Hsu, 2020, Blood.

HLA Mismatch Is Associated with Worse Outcomes after Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis from the Center for International Blood and Marrow Transplant Research.

M. Aljurf, J. Pidala, Stephanie J. Lee, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk-associations between HLA-DPB1 T cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent from HLA-DPA1

D. Miklos, Stephanie J. Lee, M. Heemskerk, 2014, Bone Marrow Transplantation.

Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality.

J. Pidala, S. Santarone, Stephanie J. Lee, 2013, Blood.

S. Spellman, M. Fernandez-Vina, C. Hurley, 2013 .

Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival.

J. Klein, M. Horowitz, Stephanie J. Lee, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem cell transplants.

E. Warren, S. Spellman, Tao Wang, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Short Telomere Length Predicts Non-Relapse Mortality after Stem Cell Transplantation for Myelodysplastic Syndrome.

D. Neuberg, Suneet Agarwal, D. Steensma, 2020, Blood.

Effects of Combined Granulocyte–Macrophage Colony-Stimulating Factor (GM-CSF), Interleukin-2, and Interleukin-12 based Immunotherapy against Intracranial Glioma in the Rat

W. Hall, W. Low, S. Spellman, 2004, Journal of Neuro-Oncology.

Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR

M. Perales, J. Pidala, B. Shaw, 2019, Blood.

HLA-A disparities illustrate challenges for ranking the impact of HLA mismatches on bone marrow transplant outcomes in the United States.

M. Horowitz, M. Maiers, S. Marsh, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Presensitization to HY antigens in female donors prior to transplant is not associated with male recipient post-transplant HY antibody development nor with clinical outcomes

L. Tian, J. Ritz, D. Miklos, 2016, Haematologica.

Shared graft-versus-leukemia minor histocompatibility antigens in DISCOVeRY-BMT

Lara E Sucheston-Campbell, Dante S. Bortone, Lara E. Sucheston-Campbell, 2022, bioRxiv.

Associations of Minor Histocompatibility Antigens with Clinical Outcomes Following Allogeneic Hematopoietic Cell Transplantation

Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, C. Haiman, 2022, bioRxiv.

The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure.

J. Klein, S. Spellman, C. Anasetti, 2007, Blood.

Donor telomere length and causes of death after unrelated hematopoietic cell transplantation in patients with marrow failure.

S. Savage, H. Katki, Stephanie J. Lee, 2018, Blood.

Reduction of brain injury using heparin to inhibit leukocyte accumulation in a rat model of transient focal cerebral ischemia. II. Dose-response effect and the therapeutic window.

P. Camarata, W. Low, S. Spellman, 1996, Journal of neurosurgery.

Germline-somatic JAK2 interactions are associated with clonal expansion in myelofibrosis

S. Chanock, H. Deeg, Jia Liu, 2022, Nature Communications.

Chromosome Y-encoded antigens associate with acute graft-versus-host disease in sex-mismatched stem cell transplant.

R. Scheuermann, A. Telenti, M. Heuer, 2018, Blood advances.

The influence of interleukin‐7 receptor α‐chain haplotypes on outcome after allogeneic hematopoietic cell transplantation

S. Spellman, N. Hellings, P. Stinissen, 2014, International journal of immunogenetics.

National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants.

S. Spellman, C. Hurley, M. Setterholm, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Specific class I HLA supertypes but not HLA zygosity or expression are associated with outcomes following HLA-matched allogeneic hematopoietic cell transplant: HLA supertypes impact allogeneic HCT outcomes.

V. Brown, K. Hsu, Stephanie J. Lee, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation.

J. Klein, M. Horowitz, P. Cano, 2013, Blood.

Cytotoxic T-lymphocyte antigen-4 single nucleotide polymorphisms are not associated with outcomes after unrelated donor transplantation: a center for international blood and marrow transplant research analysis.

Stephanie J. Lee, S. Spellman, Tao Wang, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

One-antigen mismatched related versus HLA-matched unrelated donor hematopoietic stem cell transplantation in adults with acute leukemia: Center for International Blood and Marrow Transplant Research results in the era of molecular HLA typing.

J. Sierra, Stephanie J. Lee, O. Ringdén, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Advances in the selection of HLA-compatible donors: refinements in HLA typing and matching over the first 20 years of the National Marrow Donor Program Registry.

M. Maiers, S. Spellman, M. Fernandez-Vina, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Laminin Peptide Ameliorates Brain Injury by Inhibiting Leukocyte Accumulation in a Rat Model of Transient Focal Cerebral Ischemia

A. Skubitz, P. Camarata, W. Low, 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Number of HLA mismatched eplets is not associated with major outcomes in haploidentical transplantation with post-transplantation cyclophosphamide: A Center for International Blood and Marrow Transplant Research Study.

M. Aljurf, R. Gale, Stephanie J. Lee, 2021, Transplantation and cellular therapy.

Rapid Donor Identification Improves Survival in High-Risk First-Remission Patients With Acute Myeloid Leukemia.

J. Radich, R. Larson, F. Appelbaum, 2020, JCO oncology practice.

HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia.

A. Nademanee, J. Klein, M. Horowitz, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation.

E. Reed, J. Boudreau, K. Hsu, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Allele-Level Haplotype Frequencies and Pairwise Linkage Disequilibrium for 14 KIR Loci in 506 European-American Individuals

Mary B. Stewart, E. Reed, M. Maiers, 2012, PloS one.

The impact of HLA unidirectional mismatches on the outcome of myeloablative hematopoietic stem cell transplantation with unrelated donors.

M. Aljurf, J. Pidala, Stephanie J. Lee, 2013, Blood.

Proinflammatory Cytokine and Adipokine Levels in Adult Unrelated Marrow Donors Are Not Associated with Hematopoietic Cell Transplantation Outcomes.

J. Pidala, S. Spellman, Tao Wang, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation.

A. Barrett, M. Horowitz, J. Wingard, 2009, Blood.

Analysis of non-HLA genomic risk factors in HLA-matched unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia

J. Klein, Stephanie J. Lee, S. Spellman, 2012, Haematologica.

S. Spellman, J. Panepinto, B. Logan, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Decoupling blood telomere length from age in recipients of allogeneic hematopoietic cell transplant in the BMT-CTN 1202

A. Aviv, H. Katki, Tsung-Po Lai, 2022, Frontiers in Immunology.

Relative Telomere Length before Hematopoietic Cell Transplantation and Outcome after Unrelated Donor Hematopoietic Cell Transplantation for Acute Leukemia.

S. Savage, K. Jones, Stephanie J. Lee, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Association between donor leukocyte telomere length and survival after unrelated allogeneic hematopoietic cell transplantation for severe aplastic anemia.

S. Savage, Stephanie J. Lee, I. De Vivo, 2015, JAMA.

Pre‐transplant short telomeres are associated with high mortality risk after unrelated donor haematopoietic cell transplant for severe aplastic anaemia

N. Freedman, S. Savage, H. Katki, 2019, British journal of haematology.

No Association between Donor Telomere Length and Outcomes after Allogeneic Unrelated Hematopoietic Cell Transplant in Patients with Acute Leukemia

S. Savage, K. Hsu, Stephanie J. Lee, 2017, Bone Marrow Transplantation.

The limitations of qPCR telomere length measurement in diagnosing dyskeratosis congenita

S. Savage, H. Katki, N. Giri, 2016, Molecular genetics & genomic medicine.

Changes in Expression of Transferrin, Insulin-like Growth Factor 1, and Interleukin 4 Receptors after Irradiation of Cells of Primary Malignant Brain Tumor Cell Lines

W. Hall, W. Low, S. Spellman, 2003, Radiation research.

Blueprint for the discovery of biomarkers of toxicity and efficacy for CAR T cells and T-cell engagers.

M. Perales, M. Pasquini, V. Staedtke, 2021, Blood advances.

Characteristics of Graft-versus-Host Disease (GvHD) after Post-transplant Cyclophosphamide versus Conventional GvHD Prophylaxis.

M. Perales, J. Pidala, C. Abboud, 2022, Transplantation and cellular therapy.

ABO mismatch is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation.

A. Logan, D. Miklos, K. Alimoghaddam, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Race and Survival in Unrelated Hematopoietic-cell Transplantation.

Y. Kodera, M. Malkki, S. Spellman, 2022, Transplantation and cellular therapy.

Recipient HLA-C Haplotypes and microRNA 148a/b Binding Sites Have No Impact on Allogeneic Hematopoietic Cell Transplantation Outcomes.

K. Hsu, Jeffrey S. Miller, J. Fischer, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Polymorphism in the Interleukin‐7 Receptor‐alpha and Outcome after Allogeneic Hematopoietic Cell Transplantation with Matched Unrelated Donor

S. Spellman, L. Ryder, M. Haagenson, 2013, Scandinavian journal of immunology.

State of the art review: HLA matching and outcome of unrelated donor umbilical cord blood transplants.

Anajane G. Smith, S. Spellman, C. Hurley, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Curability and transferability of atopy with allogeneic hematopoietic cell transplantation

S. Spellman, J. Brandwein, R. Leigh, 2020, Bone Marrow Transplantation.

Molecular landscape of immune pressure and escape in aplastic anemia

T. Haferlach, J. Maciejewski, Ping Zhu, 2022, Leukemia.

HLA DR15 antigen status does not impact graft-versus-host disease or survival in HLA-matched sibling transplantation for hematologic malignancies.

M. Aljurf, B. George, M. Flowers, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Genetic associations with immune-mediated outcomes after allogeneic hematopoietic cell transplantation

B. Storer, J. Hansen, S. Spellman, 2022, Blood advances.

transplantation superior to HLA-identical siblings for hematopoietic stem cell The graft-versus-leukemia effect using matched unrelated donors is not

J. Wingard, P. McCarthy, S. Spellman, 2011 .

A common allele of HLA mediates asymptomatic SARS-CoV-2 infection

J. Olgin, M. Pletcher, G. Marcus, 2022, medRxiv.

Haploidentical Vs. Matched Unrelated Donor Transplants Using Post-Transplant Cyclophosphamide for Lymphoma: A Joint CIBMTR/EBMT Study

D. Blaise, P. Dreger, Stephanie J. Lee, 2021, Blood.

Current Use and Trends in Hematopoietic Cell Transplantation in the United States.

P. Hari, M. Pasquini, M. Horowitz, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prognostic impact of pre-transplant chromosomal aberrations in peripheral blood of patients undergoing unrelated donor hematopoietic cell transplant for acute myeloid leukemia

Lara E Sucheston-Campbell, Abbas A. Rizvi, S. Chanock, 2021, Scientific Reports.

Efficacy of an osmotic pump delivered, GM-CSF-based tumor vaccine in the treatment of upper aerodigestive squamous cell carcinoma in rats

Hamid R. Djalilian, Walter A. Hall, Chap T. Le, 2007, Cancer Immunology, Immunotherapy.

New HLA haplotype frequency reference standards: high-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans.

W. Klitz, M. Maiers, S. Spellman, 2003, Tissue antigens.

DNA-methylation-based telomere length estimator: comparisons with measurements from flow FISH and qPCR

S. Horvath, S. Savage, H. Katki, 2021, Aging.

Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis.

J. Klein, M. Horowitz, S. Spellman, 2011, The Lancet. Oncology.

Tacrolimus versus Cyclosporine after Hematopoietic Cell Transplantation for Acquired Aplastic Anemia.

M. Tallman, R. Gale, M. Flowers, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

HLAMatchmaker-defined triplet matching is not associated with better survival rates of patients with class I HLA allele mismatched hematopoietic cell transplants from unrelated donors.

Tao Wang, Machteld Oudshoorn, M. Horowitz, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplantation Outcomes: A Center for International Blood and Marrow Transplant Research Analysis. Implications during the COVID-19 Pandemic.

M. Horowitz, J. Wingard, B. Shaw, 2021, Transplantation and cellular therapy.

HLA mismatching within or outside of cross-reactive groups (CREGs) is associated with similar outcomes after unrelated hematopoietic stem cell transplantation.

J. Klein, S. Takemoto, S. Spellman, 2007, Blood.

Validation of genetic associations with acute GVHD and nonrelapse mortality in DISCOVeRY-BMT.

Lara E Sucheston-Campbell, Abbas A. Rizvi, Lara E. Sucheston-Campbell, 2019, Blood advances.

Donor KIR B Genotype Improves Progression-Free Survival of Non-Hodgkin Lymphoma Patients Receiving Unrelated Donor Transplantation.

P. Parham, Jeffrey S. Miller, S. Marsh, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia.

Chap T Le, Tao Wang, John P Klein, 2010, Blood.

Broad spectrum antibiotics and risk of graft-versus-host disease in pediatric patients transplanted for acute leukemia: association of carbapenem use with risk of acute GVHD.

M. Hall, S. Spellman, Tao Wang, 2021, Transplantation and cellular therapy.

Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia

J. Klein, M. Horowitz, J. Wingard, 2014, Clinical Cancer Research.

Interleukin-12-based immunotherapy against rat 9L glioma.

W. Hall, W. Low, S. Spellman, 1998, Neurosurgery.

Immunization with Dendritic Cells Pulsed with Tumor Extract Increases Survival of Mice Bearing Intracranial Gliomas

W. Hall, W. Low, S. Spellman, 2004, Journal of Neuro-Oncology.

Donor whole blood DNA methylation is not a strong predictor of acute graft versus host disease in unrelated donor allogeneic haematopoietic cell transplantation

P. Dhami, V. Rakyan, A. Feber, 2022, medRxiv.

Analysis of Single Nucleotide Polymorphisms in the Gamma Block of the Major Histocompatibility Complex in Association with Clinical Outcomes of Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Study.

K. Hsu, Stephanie J. Lee, A. Madbouly, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Analysis of Single Nucleotide Polymorphisms in the Gamma Block of the Major Histocompatibility Complex in Association with Clinical Outcomes of Hematopoietic Cell Transplantation: A CIBMTR Study

K. Hsu, Stephanie J. Lee, A. Madbouly, 2019 .

Mapping MHC haplotype effects in unrelated donor hematopoietic cell transplantation.

M. Horowitz, M. Malkki, S. Spellman, 2013, Blood.

TRANSPLANTATION Mapping MHC haplotype effects in unrelated donor hematopoietic cell transplantation

M. Malkki, S. Spellman, Tao Wang, 2013 .

MHC-Resident Variation Affects Risks After Unrelated Donor Hematopoietic Cell Transplantation

M. Horowitz, M. Malkki, S. Spellman, 2012, Science Translational Medicine.

Petersdorf Hematopoietic Cell Transplantation MHC-Resident Variation Affects Risks After Unrelated Donor

M. Horowitz, M. Malkki, S. Spellman, 2012 .

Mapping MHC-resident transplantation determinants.

F. Christiansen, M. Horowitz, M. Malkki, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The clinical and functional effects of TERT variants in myelodysplastic syndrome.

D. Neuberg, J. Garber, Suneet Agarwal, 2021, Blood.

Genetic association with B-cell acute lymphoblastic leukemia in allogeneic transplant patients differs by age and sex.

Lara E Sucheston-Campbell, Abbas A. Rizvi, Lara E. Sucheston-Campbell, 2017, Blood advances.

Replication and validation of genetic polymorphisms associated with survival after allogeneic blood or marrow transplant.

Lara E Sucheston-Campbell, Abbas A. Rizvi, Lara E. Sucheston-Campbell, 2017, Blood.

Neuroprotection by a Bile Acid in an Acute Stroke Model in the Rat

C. Steer, W. Low, S. Spellman, 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry.

Loren Gragert, Martin Maiers, Mary Horowitz, 2014, The New England journal of medicine.

Impact of Epigenomic Hypermethylation at TP53 on Allogeneic Hematopoietic Cell Transplantation Outcomes for Myelodysplastic Syndromes

S. Spellman, A. Nazha, Yung-Tsi Bolon, 2021, Transplantation and cellular therapy.

The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy.

J. Dipersio, M. Perales, M. Maiers, 2016, Blood.

HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation.

M. Carrington, C. Witt, R. Apps, 2014, Blood.

Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.

Medhat Askar, Effie W Petersdorf, Kwang Woo Ahn, 2014, Blood.

Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study.

Effie W Petersdorf, Mari Malkki, Katharina Fleischhauer, 2012, The Lancet. Oncology.

High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.

Harriet Noreen, Marcelo Fernandez-Vina, John Klein, 2007, Blood.

The clinical and functional effects of TERT variants in myelodysplastic syndrome

D. Neuberg, J. Garber, Suneet Agarwal, 2021, bioRxiv.

Pre-HCT mosaicism increases relapse risk and lowers survival in acute lymphoblastic leukemia patients post-unrelated HCT.

Lara E Sucheston-Campbell, S. Chanock, C. Haiman, 2021, Blood advances.

Pathogenicity and impact of HLA class I alleles in aplastic anemia patients of different ethnicities

D. Monos, T. Olson, A. Bertuch, 2022, JCI insight.

A Model of Minor Histocompatibility Antigens in Allogeneic Hematopoietic Cell Transplantation

Benjamin D. Heavner, B. Storer, D. Geraghty, 2021, Frontiers in Immunology.

Visualization of Antigen-Specific T Cell Activation in Vivo in Response to Intracerebral Administration of a Xenopeptide

W. Low, S. Spellman, R. Merica, 2000, Experimental Neurology.

survival after unrelated transplantation for acute myelogenous leukemia Donor selection for natural killer cell receptor genes leads to superior

J. Klein, C. Le, P. Parham, 2010 .

A perspective on the selection of unrelated donors and cord blood units for transplantation.

Brent R Logan, M. Horowitz, S. Spellman, 2012, Blood.

A high degree of HLA disparity arises from limited allelic diversity: analysis of 1775 unrelated bone marrow transplant donor-recipient pairs.

A. Begovich, W. Hildebrand, S. Spellman, 2007, Human immunology.

The effect of NIMA matching in adult unrelated mismatched hematopoietic stem cell transplantation – a joint study of the Acute Leukemia Working Party of the EBMT and the CIBMTR

A. Nagler, M. Mohty, K. Hsu, 2018, Bone Marrow Transplantation.

Recommendations for donor human leukocyte antigen assessment and matching for allogeneic stem cell transplantation: consensus opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN).

F. Appelbaum, M. Pasquini, M. Horowitz, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Recommendations for Donor HLA Assessment and Matching for Allogeneic Stem Cell Transplantation : Consensus Opinion of the Blood and Marrow Transplant Clinical Trials Network ( BMT CTN )

F. Appelbaum, M. Pasquini, M. Horowitz, 2014 .

Birth order and transplantation outcome in HLA-identical sibling stem cell transplantation: an analysis on behalf of the Center for International Blood and Marrow Transplantation.

A. Ganser, D. Miklos, M. Aljurf, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Likelihood of Proceeding to Allogeneic Hematopoietic Cell Transplantation in the United States after Search Activation in the National Registry: Impact of Patient Age, Disease and Search Prognosis.

B. Shaw, S. Spellman, S. Devine, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor Killer Cell Ig-like Receptor B Haplotypes, Recipient HLA-C1, and HLA-C Mismatch Enhance the Clinical Benefit of Unrelated Transplantation for Acute Myelogenous Leukemia

J. Klein, P. Parham, Jeffrey S. Miller, 2014, The Journal of Immunology.

Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.

Tao Wang, Thomas Spitzer, Daniel J Weisdorf, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Epigenetic Aging and Hematopoietic Cell Transplantation in Patients With Severe Aplastic Anemia.

S. Horvath, B. Zhu, Stephanie J. Lee, 2021, Transplantation and cellular therapy.

Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors.

Effie W Petersdorf, John Horan, Michelle Setterholm, 2010, Blood.

Analysis of Whole CDR3 TCR Repertoire after Hematopoietic Stem Cell Transplantation in Two Clinical Cohorts.

J. Zehnder, S. Nikiforow, S. Spellman, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Identification by random forest method of HLA class I amino acid substitutions associated with lower survival at day 100 in unrelated donor hematopoietic cell transplantation

John P. Klein, Martin Maiers, T. Andrew Binkowski, 2011, Bone Marrow Transplantation.

Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse.

A. Gratwohl, J. Szer, M. Horowitz, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy.

J. Klein, M. Horowitz, F. Locatelli, 2014, Blood.

Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation.

J. Klein, D. Friedman, K. Ballen, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The outcomes of family haploidentical hematopoietic stem cell transplantation in hematologic malignancies are not associated with patient age.

D. Miklos, Stephanie J. Lee, S. Spellman, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Validation of short‐term handling and storage conditions for marrow and peripheral blood stem cell products

J. Ritz, S. Spellman, C. Vierra-Green, 2011, Transfusion.

Novel HLA-DP region susceptibility loci associated with severe acute GvHD

R. Ferrell, S. Spellman, M. Trucco, 2017, Bone Marrow Transplantation.

Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies.

J. Wagner, J. Kurtzberg, E. Shpall, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effect of cord blood processing on transplantation outcomes after single myeloablative umbilical cord blood transplantation.

J. Kurtzberg, A. Nagler, E. Shpall, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation.

R. Vij, M. Aljurf, R. Gale, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Recovery of Unrelated Donors of Peripheral Blood Stem Cells versus Recovery of Unrelated Donors of Bone Marrow: A Prespecified Analysis from the Phase III Blood and Marrow Transplant Clinical Trials Network Protocol 0201.

J. Wingard, S. Spellman, G. Switzer, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Three-year outcomes in recipients of mismatched unrelated bone marrow donor transplants using post-transplant cyclophosphamide: follow-up from a National Marrow Donor Program-sponsored prospective clinical trial.

M. Norkin, M. Perales, J. Pidala, 2022, Transplantation and cellular therapy.

Unlicensed umbilical cord blood units provide a safe and effective graft source for a diverse population: A study of 2456 umbilical cord blood recipients.

J. Kurtzberg, E. Shpall, K. Ballen, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

National Marrow Donor Program–Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide

M. Norkin, M. Perales, M. Horowitz, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Excellent Outcomes in 1589 Patients Receiving Umbilical Cord Blood Transplantation Using Unlicensed Units From a Centralized Cord Blood Registry

J. Kurtzberg, E. Shpall, K. Ballen, 2017 .

How transplant centers deal with the dextran shortage: recommendations for comparing alternatives

J. Kurtzberg, S. Spellman, C. Brady, 2016, Transfusion.

Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study.

M. Carrington, E. Tholouli, C. Crawley, 2019, The Lancet. Haematology.

Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation.

M. Aljurf, Stephanie J. Lee, S. Marsh, 2014, Blood.

S. Spellman, M. Setterholm, D. Weisdorf, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

HLA Informs Risk Predictions after Haploidentical Stem Cell Transplantation with Post-transplantation Cyclophosphamide.

Shannon R. McCurdy, M. Grunwald, Stephanie J. Lee, 2021, Blood.

Current Knowledge and Practice of Pediatric Providers in Umbilical Cord Blood Banking

S. Spellman, Amy E Armstrong, R. Fonstad, 2018, Clinical pediatrics.

Evaluation of peripheral blood stem cell quality in products transported by traditional courier or commercial overnight shipping services

S. Spellman, E. Waller, W. Harris, 2014, Transfusion.

Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy.

J. Kurtzberg, A. Nagler, J. Larghero, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Recovery of Unrelated Donors of Peripheral Blood Stem Cells versus Bone Marrow: A Prespecified Analysis from the Phase III BMT CTN Protocol 0201

J. Wingard, S. Spellman, G. Switzer, 2016 .

Chromosomal Aberrations and Survival after Unrelated Donor Hematopoietic Stem Cell Transplant in Patients with Fanconi Anemia.

S. Chanock, M. Yeager, S. Savage, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders.

Tao Wang, John Horan, Machteld Oudshoorn, 2012, Blood.

Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCT.

M. Aljurf, R. Gale, J. Pidala, 2020, Journal of Clinical Oncology.

GVHD after umbilical cord blood transplantation for acute leukemia: an analysis of risk factors and effect on outcomes

M. Aljurf, I. Lewis, R. Gale, 2016, Bone Marrow Transplantation.

Allele-level HLA matching for umbilical cord blood transplantation for non-malignant diseases in children: a retrospective analysis.

J. Kurtzberg, P. Veys, M. Horowitz, 2017, The Lancet. Haematology.

Impact of HLA Alleles on Outcomes of Allogeneic Transplantation for B Cell Non-Hodgkin Lymphomas: A Center for International Blood and Marrow Transplant Research Analysis.

K. Hsu, Stephanie J. Lee, S. Spellman, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Role of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor Transplantation.

M. Carrington, M. Horowitz, M. Malkki, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

In silico prediction of nonpermissive HLA-DPB1 mismatches in unrelated HCT by functional distance.

K. Hsu, J. Pidala, Stephanie J. Lee, 2018, Blood advances.

Donor-specific anti-HLA antibodies in unrelated hematopoietic cell transplantation for non-malignant disorders

K. Hsu, Stephanie J. Lee, S. Spellman, 2018, Bone Marrow Transplantation.

Telomere length and epigenetic clocks as markers of cellular aging: a comparative study

S. Savage, B. Hicks, S. Spellman, 2022, GeroScience.

Telomere Length Calibration from qPCR Measurement: Limitations of Current Method

S. Savage, H. Katki, K. Jones, 2018, Cells.

Characterization and Function of Cryopreserved Bone Marrow from Deceased Organ Donors: A Potential Viable Alternative Graft Source

K. Pollok, S. Spellman, J. Woods, 2022, Transplantation and cellular therapy.

Genome-wide Association Study Identifies HLA-DPB1 as a Significant Risk Factor for Severe Aplastic Anemia.

J. Cerhan, M. Carrington, N. Rothman, 2020, American journal of human genetics.

Pre-Transplant C-Reactive Protein (CRP), Ferritin and Albumin As Biomarkers to Predict Transplant Related Mortality (TRM) after Allogeneic Hematopoietic Cell Transplant (HCT)

M. Pasquini, U. Popat, Xiaochun Zhu, 2014 .

DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant.

S. Zeger, G. Gui, C. Hourigan, 2023, JAMA.

Evaluation of Human Leukocyte Antigen (HLA) Matching Requirements for Unrelated Peripheral Blood Stem Cell (PBSC) Transplantation

J. Klein, Stephanie J. Lee, O. Ringdén, 2008 .

HLA-Mismatch Is Associated With Worse Outcomes After Unrelated Donor Reduced Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis From The CIBMTR

M. Aljurf, Stephanie J. Lee, S. Spellman, 2015 .

Genotype List String: a grammar for describing HLA and KIR genotyping results in a text string

S G E Marsh, M Maiers, J A Hollenbach, 2013, Tissue antigens.

The effect of the composition of unrelated donor bone marrow and peripheral blood progenitor cell grafts on transplantation outcomes.

J. Wagner, S. Spellman, M. Setterholm, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation.

R. Vij, M. Aljurf, R. Gale, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Establishment of Definitions and Review Process for Consistent Adjudication of Cause-specific Mortality after Allogeneic Unrelated-donor Hematopoietic Cell Transplantation.

Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, D. Tritchler, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of the HLA Immunopeptidome on Survival of Leukemia Patients After Unrelated Donor Transplantation

Stephanie J. Lee, S. Marsh, S. Spellman, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hematology 2022-what is complete HLA match in 2022?

S. Spellman, 2022, Hematology. American Society of Hematology. Education Program.

Regarding "Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study".

M. Perales, J. Pidala, M. Maiers, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Scoring HLA class I mismatches by HistoCheck does not predict clinical outcome in unrelated hematopoietic stem cell transplantation.

J. Klein, R. Blasczyk, Jun He, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Following Transplantation for Acute Myelogenous Leukemia, Donor KIR Cen B02 Better Protects against Relapse than KIR Cen B01

Wesley M. Marin, P. Parham, Jeffrey S. Miller, 2021, The Journal of Immunology.

Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia

N. Kröger, M. Robin, I. Yakoub-Agha, 2021, Frontiers in Immunology.

A Detailed View of KIR Haplotype Structures and Gene Families as Provided by a New Motif-Based Multiple Sequence Alignment

R. Kuang, M. Maiers, D. Geraghty, 2020, bioRxiv.

Estimating KIR Haplotype Frequencies on a Cohort of 10,000 Individuals: A Comprehensive Study on Population Variations, Typing Resolutions, and Reference Haplotypes

R. Kuang, J. Trowsdale, M. Maiers, 2016, PloS one.

Upper gastrointestinal acute graft-versus-host disease adds minimal prognostic value in isolation or with other graft-versus-host disease symptoms as currently diagnosed and treated

S. Nikiforow, H. Nakasone, J. Pidala, 2018, Haematologica.

Donor killer-cell immunoglobulin-like receptor (KIR) genotype does not improve graft-versus-leukemia responses in chronic lymphocytic leukemia (CLL) after unrelated donor transplant: a CIBMTR analysis

P. Parham, Stephanie J. Lee, S. Spellman, 2019 .

Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.

K. Hsu, Stephanie J. Lee, O. Ringdén, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

YKL-40 in allogeneic hematopoietic cell transplantation after AML and myelodysplastic syndrome

S. Spellman, C. Müller, M. Verneris, 2016, Bone Marrow Transplantation.

Impact of Previously Unrecognized HLA Mismatches Using Ultrahigh Resolution Typing in Unrelated Donor Hematopoietic Cell Transplantation

V. Bhatt, Stephanie J. Lee, B. Shaw, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MHC Class I Chain-Related Gene A (MICA) Donor-Recipient Mismatches and MICA-129 Polymorphism in Unrelated Donor Hematopoietic Cell Transplantations Has No Impact on Outcomes in Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome: A Center for International Blood and Mar

K. Hsu, Stephanie J. Lee, A. Madbouly, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prediction of absolute risk of acute graft-versus-host disease following hematopoietic cell transplantation

Sherri Rose, S. Haneuse, K. Hsu, 2018, PloS one.

KIR2DL5 alleles mark certain combination of activating KIR genes

E. Reed, S. Spellman, R. Rajalingam, 2008, Genes and Immunity.

A combined DPA1∼DPB1 amino acid epitope is the primary unit of selection on the HLA-DP heterodimer

A. Begovich, B. Shaw, A. Madbouly, 2012, Immunogenetics.

Significance of ethnicity in the risk of acute graft-versus-host disease and leukemia relapse after unrelated donor hematopoietic stem cell transplantation.

A. Velardi, M. Malkki, S. Spellman, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Genetic risk variants in African Americans with multiple sclerosis

P. D. De Jager, H. Harbo, L. Piccio, 2013, Neurology.

Insufficient evidence for association of NOD2/CARD15 or other inflammatory bowel disease-associated markers on GVHD incidence or other adverse outcomes in T-replete, unrelated donor transplantation.

N. Davidson, Stephanie J. Lee, Ellen Li, 2010, Blood.

Progress toward curing HIV infection with hematopoietic cell transplantation

J. Burnett, J. Kurtzberg, E. Shpall, 2015, Stem cells and cloning : advances and applications.

Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis.

J. Klein, M. Horowitz, J. Wingard, 2011, Blood.

Exome chip analyses identify genes affecting mortality after HLA-matched unrelated-donor blood and marrow transplantation.

Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, C. Haiman, 2018, Blood.

Novel genetic variants associated with mortality after unrelated donor allogeneic hematopoietic cell transplantation

Lara E Sucheston-Campbell, Abbas A. Rizvi, Lara E. Sucheston-Campbell, 2021, EClinicalMedicine.

Neither Donor nor Recipient Mitochondrial Haplotypes Are Associated with Unrelated Donor Transplant Outcomes: A Validation Study from the CIBMTR.

Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, K. Beckman, 2021, Transplantation and cellular therapy.

Prior rituximab correlates with less acute graft‐versus‐host disease and better survival in B‐cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation

R. Gale, H. Khoury, O. Ringdén, 2009, British journal of haematology.

Worldwide sources of data in haematology: Importance of clinician-biostatistician collaboration.

S. Spellman, B. Logan, Kristin M. Page, 2023, Best practice & research. Clinical haematology.

Donor HLA-E Status Associates with Disease-Free Survival and Transplant-Related Mortality after Non In Vivo T Cell-Depleted HSCT for Acute Leukemia

K. Hsu, Stephanie J. Lee, S. Spellman, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Genetics of HLA Peptide Presentation and Impact on Outcomes in HLA-Matched Allogeneic Hematopoietic Cell Transplantation

V. Brown, B. Vincent, D. Miklos, 2021, Transplantation and Cellular Therapy.

Inferior Outcomes with Cyclosporine and Mycophenolate mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation.

M. Aljurf, R. Gale, J. Pidala, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pre-MEASURE: Multicenter evaluation of the prognostic significance of measurable residual disease testing prior to allogeneic transplantation for adult patients with AML in first remission.

G. Gui, C. Hourigan, S. Spellman, 2022, Journal of Clinical Oncology.

Directionality of non-permissive HLA-DPB1 T-cell epitope group mismatches does not improve clinical risk stratification in 8/8 matched unrelated donor hematopoietic cell transplantation

J. Pidala, B. Shaw, S. Spellman, 2017, Bone Marrow Transplantation.

Significant differences in outcome following unrelated donor HCT can be better predicted using an algorithm incorporating both allele and epitope level matching for HLA-DPB1

Mari Malkki, Stephen Spellman, Ted Gooley, 2009 .

Investigating the Association of Genetic Admixture and Donor/Recipient Genetic Disparity with Transplant Outcomes.

V. Paunic, K. Hsu, Stephanie J. Lee, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Neuronal Protection from Cerebral Ischemia by Synthetic Fibronectin Peptides to Leukocyte Adhesion Molecules

P. Camarata, W. Low, S. Spellman, 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Optimal Donor Selection for Hematopoietic Cell Transplantation Using Bayesian Machine Learning.

Purushottam W. Laud, R. McCulloch, R. Sparapani, 2021, JCO clinical cancer informatics.

Germline predisposition variants occur in myelodysplastic syndrome patients of all ages.

S. Spellman, R. Sobecks, L. Godley, 2022, Blood.

HLA mismatches that are identical for the antigen recognition domain are less immunogenic

D. Roelen, S. Spellman, F. Claas, 2018, Bone Marrow Transplantation.

Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort.

J. Klein, M. Horowitz, J. Wingard, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Improved survival after acute graft-versus-host disease diagnosis in the modern era

Alan M. Miller, R. Vij, W. Wood, 2017, Haematologica.

Cyclosporine in Combination with Mycophenolate Mofetil Leads to Increased Incidence of Graft-Versus-Host Disease and Inferior Outcomes after Myeloablative Allogeneic Hematopoietic Cell Transplantation: A CIBMTR Analysis

Y. Liu, J. Pidala, O. Ringdén, 2018 .

Trends In Incidence, Presentation, and Outcomes Of Chronic Graft-Versus-Host Disease In Allogeneic Transplantation- Report From The Center For International Blood and Marrow Transplant Research

S. Spellman, Tao Wang, M. Arora, 2013 .

The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes

M. Pasquini, A. Wickrema, U. Popat, 2016, Haematologica.

Association of Chronic Graft-versus-Host Disease with Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic Malignancy.

R. Gale, J. Pidala, L. Lekakis, 2022, Transplantation and cellular therapy.

Real-world data showing trends and outcomes by race and ethnicity in allogeneic hematopoietic cell transplantation: a report from the Center for International Blood and Marrow Transplant Research.

M. Pasquini, B. Shaw, K. Flynn, 2023, Transplantation and cellular therapy.

Haploidentical versus matched unrelated donor transplants using post-transplant cyclophosphamide for lymphomas.

D. Blaise, P. Dreger, Stephanie J. Lee, 2022, Transplantation and cellular therapy.

Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow Allografts Have Improved Long-Term Overall and Graft-versus-Host Disease-Free, Relapse-Free Survival.

J. Kanda, R. Gale, J. Pidala, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Sibling versus Unrelated Donor Allogeneic Hematopoietic Cell Transplantation for CML: Refined HLA-matching shows more GVHD but not less relapse Blood Marrow

J. Szer, M. Horowitz, Stephanie J. Lee, 2010 .

Replication of associations between genetic polymorphisms and chronic graft-versus-host disease.

Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, L. Zhao, 2016, Blood.

Analysis of a Genetic Polymorphism in the Costimulatory Molecule TNFSF4 with Hematopoietic Stem Cell Transplant Outcomes.

P. Kraft, R. Abdi, P. Jindra, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Identification of high-risk amino-acid substitutions in hematopoietic cell transplantation: a challenging task

T. A. Binkowski, T. Karrison, M. Maiers, 2016, Bone Marrow Transplantation.

HLA mismatches and hematopoietic cell transplantation: structural simulations assess the impact of changes in peptide binding specificity on transplant outcome

Mari Malkki, Chen Yanover, Philip Bradley, 2011, Immunome research.

Re: An approach to predicting HSCT outcome using HLA-mismatch information mapped on protein structure data.

M. Horowitz, Stephanie J. Lee, M. Malkki, 2010, Biology of Blood and Marrow Transplantation.

Modulation of growth factor receptor expression by irradiation for immunotoxin targeting.

W. Hall, W. Low, S. Spellman, 2001, Methods in molecular biology.

Optimal timing of hemodilution for brain protection in a canine model of focal cerebral ischemia.

P. Camarata, S. Spellman, R. Heros, 1996, Stroke.

HLA-DQ Heterodimers in Hematopoietic-Cell Transplantation.

S. Spellman, E. Petersdorf, T. Gooley, 2022, Blood.

Associations of minor histocompatibility antigens with outcomes following allogeneic hematopoietic cell transplantation

Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, Qianqian Zhu, 2023, American journal of hematology.

Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome.

D. Neuberg, Suneet Agarwal, D. Steensma, 2020, Blood.

Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation

M. Norkin, R. Vij, M. Horowitz, 2018, Bone Marrow Transplantation.

Genomic Mechanisms of SES-Related Outcome Disparities in Hematopoietic Cell Transplantation

Stephanie J. Lee, S. Spellman, Tao Wang, 2018 .

A New Immune-Competent Animal Model of Mucosally Derived Squamous Cell Carcinoma

W. Hall, H. Djalilian, W. Low, 2004, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

A core group of structurally similar HLA-DPB1 alleles drives permissiveness after hematopoietic cell transplantation.

Stephanie J. Lee, S. Marsh, S. Spellman, 2022, Blood.

Natural killer cell alloreactivity predicted by killer cell immunoglobulin-like receptor ligand mismatch does not impact engraftment in umbilical cord blood and haploidentical stem cell transplantation.

V. Brown, V. Bhatt, Stephanie J. Lee, 2022, Transplantation and cellular therapy.

Genetic testing in severe aplastic anemia is required for optimal hematopoietic cell transplant outcomes.

N. Freedman, S. Savage, B. Zhu, 2022, Blood.

Limited role of MHC class I chain-related gene A (MICA) typing in assessing graft-versus-host disease risk after fully human leukocyte antigen-matched unrelated donor transplantation.

Jeffrey S. Miller, S. Spellman, Tao Wang, 2009, Blood.

How do we improve the translation of new evidence into the practice of hematopoietic cell transplantation and cellular therapy?

W. Wood, Bryce Waldman, Z. DeFilipp, 2023, Blood reviews.

HLA Class I genotype is associated with relapse risk after allogeneic stem cell transplantation for NPM1-mutated AML.

V. Brown, A. Niroula, V. Bhatt, 2023, Transplantation and cellular therapy.

HLA typing and implications

B. Shaw, S. Spellman, 2017 .

The distribution and accumulation of the shortest telomeres in telomere biology disorders

A. Aviv, S. Savage, Tsung-Po Lai, 2023, British journal of haematology.

Genetic Alterations Predict Outcomes in Patients with Myelodysplastic Syndrome Receiving Allogeneic Hematopoietic Stem Cell Transplantation

D. Neuberg, B. Ebert, K. Hsu, 2016 .

Genotype List String 1.1: Extending the Genotype List String grammar for describing HLA and Killer‐cell Immunoglobulin‐like Receptor genotypes

M. Maiers, S. Spellman, J. Hollenbach, 2023, HLA.

Single or Multiple HLA-A, B, C or DRB1 Mismatches Limit Success of Unrelated Donor Bone Marrow Transplantation.

J. Klein, M. Horowitz, Stephanie J. Lee, 2006 .

A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection

J. Olgin, M. Pletcher, G. Marcus, 2023, Nature.

Corrigendum to 'Current Use and Trends in Hematopoietic Cell Transplantation in the United States' [Transplantation and Cellular Therapy 26/8 (2020) e177-e182].

P. Hari, M. Pasquini, M. Horowitz, 2021, Transplantation and Cellular Therapy.

Progress toward curing HIV infection with hematopoietic cell transplantation

J. Burnett, J. Kurtzberg, E. Shpall, 2015, Stem cells and cloning : advances and applications.

Whole-genome sequencing identifies novel predictors for hematopoietic cell transplant outcomes for patients with myelodysplastic syndrome: a CIBMTR study

H. Deeg, S. Spellman, S. Gadalla, 2023, Journal of Hematology & Oncology.

CD16-IL15-CD33 Trispecific Killer Engager (TriKE) Overcomes Cancer-Induced Immune Suppression and Induces Natural Killer Cell-Mediated Control of MDS and AML Via Enhanced Killing Kinetics

J. Tolar, Jeffrey S. Miller, S. Spellman, 2016 .

Stem Cells and Cloning: Advances and Applications Progress toward curing Hiv infection with hematopoietic cell transplantation

J. Burnett, J. Kurtzberg, E. Shpall, 2022 .

A pilot study of donor-engrafted clonal hematopoiesis evolution and clinical outcomes in allogeneic hematopoietic cell transplant recipients using a national registry.

T. Druley, Mingxiang Teng, J. Pidala, 2023, Transplantation and cellular therapy.

Toll-like receptor polymorphisms in allogeneic hematopoietic cell transplantation.

Stephanie J. Lee, S. Spellman, Tao Wang, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Biology of Blood and Marrow Transplantation

S. Spellman, R. Sobecks, W. Arcese, 2016 .

Genetic risk variants in African Americans with multiple sclerosis

P. D. De Jager, H. Harbo, L. Piccio, 2013, Neurology.

HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia.

A. Nademanee, M. Horowitz, S. Spellman, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia.

C. Le, P. Parham, Jeffrey S. Miller, 2010, Blood.

Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation.

K. Hsu, M. Malkki, S. Spellman, 2010, Blood.

Existence of HLA-mismatched Unrelated Donors Closes the Gap in Donor Availability Regardless of Recipient Ancestry.

M. Maiers, S. Spellman, S. Devine, 2023, Transplantation and cellular therapy.

A combined DPA1∼DPB1 amino acid epitope is the primary unit of selection on the HLA-DP heterodimer

A. Begovich, B. Shaw, M. Maiers, 2012, Immunogenetics.

Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.

W. Wood, A. Gratwohl, M. Aljurf, 2014, Blood.

Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort.

M. Horowitz, J. Wingard, R. Gale, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Association Of Graft Vs. Host Disease (GVHD) With a Lower Relapse/Progression Rate After Allogeneic Hemopoietic Stem Cell Transplantation (HSCT) With Reduced Intentsity Conditioning In Patients With Follicular and Mantle Cell Lymphoma: A Cibmtr Analysis

S. Montoto, Sonali M. Smith, D. Maloney, 2013 .

Access: A Multi-Center, Phase II Trial of HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Patients with Hematologic Malignancies

B. Shaw, S. Spellman, S. Choi, 2022, Blood.

HLA Haplotypes and Relapse After Hematopoietic Cell Transplantation

M. Malkki, S. Spellman, E. Petersdorf, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ABO mismatch is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation.

A. Logan, D. Miklos, K. Alimoghaddam, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow allografts have improved Long-term Overall and Graft-versus-Host Disease, Relapse-Free Survival Biol Blood Marrow Transplant.

J. Kanda, J. Pidala, M. Boyiadzis, 2019 .

Prognostic landscape of mitochondrial genome in myelodysplastic syndrome after stem-cell transplantation

H. Deeg, S. Spellman, S. Gadalla, 2023, Journal of Hematology & Oncology.

HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation.

R. Apps, A. Velardi, K. Hsu, 2014, Blood.

Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders.

Stephanie J. Lee, S. Spellman, Tao Wang, 2012, Blood.

TRANSPLANTATION Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality

J. Pidala, S. Santarone, M. Maiers, 2013 .

Awareness and acceptance of public cord blood banking among practicing obstetricians in the United States

S. Spellman, M. Boo, Tim Walker, 2012, Transfusion.